Cargando…
Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
PURPOSE: Teriparatide is used to treat patients with established osteoporosis but is often reserved for patients who have inadequate response to antiresorptive therapy. Biosimilar teriparatide, which is believed to have efficacy and safety similar to the originator product, is now available in Colom...
Autores principales: | Graham-Clarke, Peita L, Hauber, Brett, Boeri, Marco, Leonardi, Felice, Burge, Russel T, Fernandez, Maria, Tockhorn-Heidenreich, Antje, Florez, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323574/ https://www.ncbi.nlm.nih.gov/pubmed/32612354 http://dx.doi.org/10.2147/PPA.S250745 |
Ejemplares similares
-
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014) -
The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making
por: Mansfield, Carol, et al.
Publicado: (2022) -
Discrete Choice Experiment to Understand Japanese Patients’ and Physicians’ Preferences for Preventive Treatments for Migraine
por: Seo, Jaein, et al.
Publicado: (2023) -
Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study
por: Tanaka, Ikuko, et al.
Publicado: (2013) -
Patient and physician preferences for ulcerative colitis treatments in the United States
por: Boeri, Marco, et al.
Publicado: (2019)